Skip to main content

Liver and bile duct.

3 Phase 1 studies recruiting right now, most recently updated first.

Liver and bile duct3 studies

Liver CancerNCT04715191

CARE T cells

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Baylor College of MedicineOpen the brief

Hepatocellular CarcinomaNCT05003895

CAR-T cell

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

National Cancer Institute (NCI)Open the brief

Fibrolamellar Hepatocellular Carcinoma (FLC)NCT04248569Papers

DNAJB1-PRKACA peptide vaccine

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOpen the brief

Phase 1 — first-in-human trials, explained